drugset / Trial / NCT01433757

Ampicillin for DYT-1 Dystonia Motor Symptoms

NCT01433757

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate if the antibiotic Ampicillin is safe and tolerated in patients that have generalized dystonia caused by the DYT-1 gene mutation, as compared to patients treated with a placebo. A placebo is a pill that looks and tastes the same as the real drug, but without the active ingredient. The second objective of this study is to determine if dystonia symptoms improve while on the study drug.

Timeline

Start
2011-09
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ampicillin Unknown 1 mg Oral
Comparator Ampicillin Unknown 2 mg Oral

Indications